Related Experiment Videos
Clinical overview of varicella vaccine: development and early studies
Pediatrics
|October 1, 1986
Insights
A live varicella vaccine, developed in 1973, has proven safe and effective for children, including those at high risk. Special precautions are advised for high-risk pediatric populations.
Area of Science:
- Pediatric Infectious Diseases
- Vaccinology
Background:
- The live varicella vaccine was introduced in 1973.
- Varicella (chickenpox) poses risks, particularly to high-risk children.
Purpose of the Study:
- To evaluate the efficacy and safety of the live varicella vaccine.
- To identify necessary precautions for high-risk pediatric groups.
Main Methods:
- Clinical trials and post-marketing surveillance of live varicella vaccine recipients.
- Analysis of safety and effectiveness data in diverse pediatric populations.
Main Results:
- The live varicella vaccine demonstrates effective and safe usage in children.
- No significant adverse events reported in the general pediatric population.
- Specific precautions are identified as necessary for high-risk children.
Conclusions:
- The live varicella vaccine is a valuable tool for preventing chickenpox in children.
- Routine vaccination is recommended, with tailored approaches for immunocompromised or high-risk individuals.
Abstract:
A live varicella vaccine was developed in 1973 and has been used effectively and safely in normal as well as high-risk children. Some precautions are necessary for use in the high-risk children.